<DOC>
	<DOCNO>NCT01911858</DOCNO>
	<brief_summary>The purpose study demonstrate Askina® Calgitrol® Paste safe use III degree burn quantify concentration silver blood treatment thus show amount silver absorb great reported literature .</brief_summary>
	<brief_title>Askina Calgitrol Paste Burns</brief_title>
	<detailed_description />
	<mesh_term>Burns</mesh_term>
	<criteria>Adults ( ≥ &gt; 18 year age ) . No upper age limit III degree thermal burn 230 % TBSA determine Rule Nines Patients underwent initial treatment within 24 hour injury late Patients underwent initial treatment directly Burn Centre FNKV initial treatment accordance standard care Centre All patient hospitalise Patients capable give signing informed consent do . Patients electrical chemical burn Patients already infected wound Patients take systemic antibiotic admission Patients pregnant lactate Patients fall `` vulnerable population '' group respect inform consent capable give informed consent Patients use treat silver product reason treatment acute burn last 3 month Patients whose burn wound treat silver product . Patients receive renal dialysis Known allergy sensitivity ingredient Askina® Calgitrol® Paste . Simultaneous participation another interventional clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>